⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27393378 | 0.69 | — | — | |
| SCHEMBL1123008 | 0.68 | — | — | |
| SCHEMBL28800262 | 0.67 | — | — | |
| SCHEMBL27452190 | 0.65 | LMNA (0.39) | — | |
| SCHEMBL26400712 | 0.65 | — | — | |
| SCHEMBL12657669 | 0.65 | — | — | |
| SCHEMBL28846524 | 0.65 | — | — | |
| Urea SCHEMBL8587560 | 0.63 | — | — | |
| SCHEMBL22686142 | 0.63 | — | — | |
| N-Methyl-N-Nitrosurea SCHEMBL38377 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2538944-B1 | COMPOUND FOR TREATING BRAIN CANCER | NIIKI PHARMA INC (US) | 2014-10-22 | — | — | EP | claimed |
| US-20250195443-A1 | Polymer Nanoaggregate Pharmaceutical Composition and Use Thereof | ANP TECHNOLOGIES, INC. (US) | 2025-06-19 | — | — | US | disclosed |
| US-20250099432-A1 | LIQUID PHARMACEUTICAL FORMULATION | PROJECT PHARMACEUTICS GMBH (DE) | 2025-03-27 | — | — | US | disclosed |
| US-12161631-B2 | Liquid pharmaceutical formulation | PROJECT PHARMACEUTICS GMBH (DE) | 2024-12-10 | — | — | US | disclosed |
| EP-3773498-B1 | LIQUID PHARMACEUTICAL FORMULATION | PROJECT PHARMACEUTICS GMBH (DE) | 2022-06-22 | — | — | EP | disclosed |
| CN-113398070-A | Fractionated radiotherapy and chemotherapy using oxygen therapy | 埃文·C·昂格尔 | 2021-09-17 | — | — | CN | disclosed |
| EP-3552617-B1 | DRUG RESISTANT IMMUNOTHERAPY FOR TREATMENT OF A CANCER | UNIV EMORY (US) | 2021-07-07 | — | — | EP | disclosed |
| US-20200323903-A1 | DRUG RESISTANT IMMUNOTHERAPY FOR TREATMENT OF A CANCER | EMORY UNIVERSITY (US) | 2020-10-15 | — | — | US | disclosed |
| US-10543233-B2 | Drug resistant immunotherapy for treatment of a cancer | EMORY UNIVERSITY (US) | 2020-01-28 | — | — | US | disclosed |
| EP-3552617-A1 | DRUG RESISTANT IMMUNOTHERAPY FOR TREATMENT OF A CANCER | Emory University (US) | 2019-10-16 | — | — | EP | disclosed |
| EP-2429527-A1 | NEW COMBINATION THERAPY IN TREATMENT OF CANCER AND FIBROTIC DISEASES | Boehringer Ingelheim International GmbH (DE) | 2012-03-21 | — | — | EP | disclosed |
| WO-2011134898-A1 | NEW COMBINATION THERAPY IN TREATMENT OF ONCOLOGICAL AND FIBROTIC DISEASES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-11-03 | — | — | WO | disclosed |
| WO-2011053750-A2 | DRUG RESISTANT IMMUNOTHERAPY FOR TREATMENT OF A CANCER | EMORY UNIVERSITY (US) | 2011-05-05 | — | — | WO | disclosed |
| WO-2010130758-A1 | NEW COMBINATION THERAPY IN TREATMENT OF CANCER AND FIBROTIC DISEASES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-11-18 | — | — | WO | disclosed |
| WO-2010130757-A1 | NEW COMBINATION THERAPY IN TREATMENT OF ONCOLOGICAL AND FIBROTIC DISEASES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-11-18 | — | — | WO | disclosed |
| WO-2010036936-A2 | USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH ANTICANCER AGENTS | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2010-04-01 | — | — | WO | disclosed |
| US-6252048-B1 | FUSION PROTEIN FOR THE TREATMENT AND PREVENTION OF CANCER | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE | 2001-06-26 | — | — | US | disclosed |
| US-6046036-A | FOR INCREASING SURVIVAL RATE OF NON-TARGET CELLS SUCH AS HEMATOPOIETIC CELLS WHEN CONTACTED WITH ANTICARCINOGENIC/DNA-DAMAGING AGENTS DURING MULTIAGENT CHEMOTHERAPY PROTOCOLS OR IN FANCONI'S ANEMIA | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE (US) | 2000-04-04 | — | — | US | disclosed |
| WO-1999025386-A1 | delta-O6-METHYLGUANINE-DNA METHYLTRANSFERASE GENE TRANSFER FOR O6-BENZYLGUANINE AND (N,N'-BIS(2-CHLOROETHYL)-N-NITROSOUREA) RESISTANCE | CASE WESTERN RESERVE UNIVERSITY (US) | 1999-05-27 | — | — | WO | disclosed |
| WO-1998017684-A2 | DNA SEQUENCES ENCODING FUSIONS OF DNA REPAIR PROTEINS AND USES THEREOF | ADVANCED RESEARCH & TECHNOLOGY INSTITUTE (US) | 1998-04-30 | — | — | WO | disclosed |